SG HealthCare Co., Ltd. (KOSDAQ:398120)
South Korea · Delayed Price · Currency is KRW 3,970.00
-60.00 (-1.49%)
At close: Apr 9, 2026
SG HealthCare Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 935.6 | -3,547 | 1,767 | -450.94 |
Depreciation & Amortization | 639.51 | 369.2 | 303.78 | 295.63 |
Loss (Gain) From Sale of Assets | 110.54 | 71.42 | - | -1.53 |
Asset Writedown & Restructuring Costs | -5 | 13 | 84.13 | - |
Loss (Gain) From Sale of Investments | -32.23 | - | - | 1.36 |
Loss (Gain) on Equity Investments | - | - | 0.91 | 1.15 |
Stock-Based Compensation | 33.92 | 227.3 | 279.41 | 284.56 |
Provision & Write-off of Bad Debts | 256.22 | 671.8 | 256.97 | 35.27 |
Other Operating Activities | 993.72 | 2,358 | 801 | 3,168 |
Change in Accounts Receivable | -7,247 | 3,487 | -4,753 | 1,075 |
Change in Inventory | -1,783 | -455.64 | 2,830 | -6,144 |
Change in Accounts Payable | 3,036 | -1,635 | 929 | -1,384 |
Change in Other Net Operating Assets | -1,176 | -449.02 | -1,892 | 1,453 |
Operating Cash Flow | -4,238 | 1,111 | 606.47 | -1,666 |
Operating Cash Flow Growth | - | 83.16% | - | - |
Capital Expenditures | -1,698 | -4,047 | -1,039 | -279.62 |
Sale of Property, Plant & Equipment | 5.85 | 4.11 | - | 1.55 |
Sale (Purchase) of Intangibles | -952.2 | 215 | -272.11 | - |
Sale (Purchase) of Real Estate | - | - | - | -86.25 |
Investment in Securities | - | 23.95 | 9.64 | 2,621 |
Other Investing Activities | -66.84 | -0.42 | -4.03 | -87.2 |
Investing Cash Flow | -2,711 | -3,804 | -1,306 | 2,170 |
Short-Term Debt Issued | 2,000 | 3,490 | 7,337 | 2,437 |
Long-Term Debt Issued | 465 | 1,726 | - | - |
Total Debt Issued | 2,465 | 5,216 | 7,337 | 2,437 |
Short-Term Debt Repaid | -943.26 | -7,950 | -6,984 | -1,204 |
Long-Term Debt Repaid | -104.78 | -100.75 | -779.11 | -440.58 |
Total Debt Repaid | -1,048 | -8,050 | -7,763 | -1,644 |
Net Debt Issued (Repaid) | 1,417 | -2,834 | -426.64 | 792.93 |
Issuance of Common Stock | 411.25 | - | - | - |
Repurchase of Common Stock | -75.88 | - | - | - |
Other Financing Activities | 138.99 | 11,307 | 33.16 | -0 |
Financing Cash Flow | 1,891 | 8,473 | -393.47 | 792.93 |
Foreign Exchange Rate Adjustments | -36.31 | 64.1 | -15.74 | -219.71 |
Miscellaneous Cash Flow Adjustments | -360.61 | -0 | -0 | - |
Net Cash Flow | -5,455 | 5,844 | -1,108 | 1,077 |
Free Cash Flow | -5,936 | -2,936 | -432.66 | -1,946 |
Free Cash Flow Margin | -24.13% | -18.23% | -1.56% | -7.63% |
Free Cash Flow Per Share | -539.27 | -319.44 | -56.01 | -323.67 |
Cash Interest Paid | 237.96 | 480.14 | 442.29 | 333.34 |
Cash Income Tax Paid | -28.85 | 466.59 | 46.43 | 3.59 |
Levered Free Cash Flow | -7,642 | -2,110 | -6,273 | - |
Unlevered Free Cash Flow | -7,401 | -1,807 | -5,638 | - |
Change in Working Capital | -7,170 | 947.53 | -2,887 | -5,000 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.